Download FREE Report Sample
Download Free sampleChemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this era postponed, or even refused, potentially curative treatments. Since the 1990s, several novel classes of antiemetics have been developed and commercialized, becoming a nearly universal standard in chemotherapy regimens, and helping to better manage these symptoms in a large portion of patients. Efficient mediation of these unpleasant and sometimes crippling symptoms results in increased quality of life for the patient, and better overall health of the patient, and, due to better patient tolerance, more effective treatment cycles.
Chemotherapy Induced Nausea and Vomiting Drugs Market contains market size and forecasts of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs in global, including the following market information:
The global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market was valued at 2125.8 million in 2021 and is projected to reach US$ 2819.2 million by 2028, at a CAGR of 4.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
5-HT3 Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs include Merck, Eisai, Mundipharma, Qilu Pharma, Teva, Novartis, Heron Therapeutics, Roche and Mylan and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Segment Percentages, by Type, 2021 (%)
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Segment Percentages, by Application, 2021 (%)
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Segment Percentages, By Region and Country, 2021 (%)
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
